Clinical Trials Logo

Clinical Trial Summary

The proposed research project provides a novel approach to screening, early assessment, and preventive interventions for high-risk youth in racial/ethnic/linguistically (REL)-diverse communities. - The investigators assess a health promotion intervention as a way of reducing treatment disparities in REL-minority youth. This population is underrepresented in child psychiatry research. It is often excluded from clinical trials of medication or therapy because of challenges with transportation, literacy, resources, or other issues. - The study will take place during or following a healthcare crisis and economic recession, making findings relevant to understanding the mechanisms by which hardship translates into youth mental illness. - The innovative integration of online screening into school-based clinics and community-based settings in REL-minority communities is made possible by the combination of access to a new technology (CAT) in the context of a learning health community serving a REL-minority population. - Empirical research on the impact of a resilience-based prevention intervention in youth and youth at risk is both innovative and much needed during this period of health, social and economic crisis.


Clinical Trial Description

Four hundred high school students will be screened for psychiatric symptoms and functional impairment using the Kiddie Computerized Adaptive Testing (K-CAT) and the Weiss Functional Impairment Rating Scale - Self Report (WFIRS-S) in CHA's catchment area (Cambridge, Chelsea, Everett, Malden, Revere, Somerville, Winthrop. Students will be classified into three tiers: normal, at risk, and clinical . The cut off scores that differentiate the tiers are drawn from the ROC values generated by the psychometrics of the measures themselves as follows: - Tier 1: K-CAT Normal & WFIRS <0.8 - >1.0 (T <1SD). - Tier 2: K-CAT Mild & WFIRS 0.8 - >1.0, K-CAT Moderate & WFIRS 0.8 - 1.0 (T between 1 and 1.5 SD), K-CAT Severe & WFIRS 0.8 - 1.0 (T between 1 and 1.5 SD) - Tier 3: K-CAT Moderate & WFIRS >1.0 (T >1.5 SD), K-CAT Severe & WFIRS >1.0 (T >1.5 SD) If patients are symptomatic but not functionally impaired, status is determined by function because symptoms without impairment do not necessarily warrant intervention. If the patient is impaired but not symptomatic, the threshold is determined by symptoms because the patient may be impaired from factors other than the diagnosis. These scores are based on the results of the most severe module of either the K-CAT or the WFIRS. .All students will be eligible to participate in C2T, independent of how they are classified by Tier, unless they meet one of the exclusion criteria. Tier 3 will be informed that the participants' responses suggest that the participants are experiencing some symptoms which are causing them difficulty. As long as the participants are not assessed as critical imminent risk, Tier 3 will also be invited to participate in C2T. A stepped wedge design with 3 clusters of 36 students each will be used to group students into clusters based on rolling recruitment into COPE2Thrive. The stepped wedge design assigns a random cluster to be switched from the control group to the C2T intervention group at either one, two, or three-week intervals starting at week 1 and ending at week 23 of the study. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04935710
Study type Interventional
Source Cambridge Health Alliance
Contact Margaret D Weiss, MD PhD
Phone 617-665-13338
Email madweiss@challiance.org
Status Recruiting
Phase Phase 1
Start date January 3, 2022
Completion date December 31, 2024

See also
  Status Clinical Trial Phase
Completed NCT05120167 - Strategies for Endocervical Canal Investigation in Women With Abnormal Screening Cytology and Negative Colposcopy N/A
Completed NCT01820234 - Evaluation of Store-and-Forward Teledermatology Versus a Face-to-Face Assessment During a Skin Cancer Screening Event N/A
Completed NCT01140022 - Leveraging Technology as a Clinician Extender to Screen Culturally Diverse Young Women for Chlamydia N/A
Completed NCT04240418 - Initiative in LYon for Lung cAncer Screening Development - Prevalence Study
Recruiting NCT03937583 - Screening for Cancer in Patients With Unprovoked VTE Phase 4
Completed NCT00115557 - Delivery of Preventive Services in Primary Care N/A
Recruiting NCT05880173 - SCREaning of Advanced Liver Fibrosis Using Non-Invasive Tests in General Population N/A
Recruiting NCT05884840 - New Cardiovascular Risk Screening Strategy. N/A
Recruiting NCT05460975 - Breast Cancer Risk From Sonographic Glandular Tissue Component (or International GTC Study)
Not yet recruiting NCT06416501 - The Impact of Colorectal Cancer Screening on Surgical Outcomes
Completed NCT02727894 - Colorectal Cancer: Screening vs. Non-Screening
Active, not recruiting NCT03861741 - A Study to Evaluate the Feasibility of Screening Relatives of Patients Affected by Non-Syndromic Thoracic Aortic Diseases N/A
Completed NCT04644874 - Geriatric Oncology Screening of Older Patients With Solid Cancers
Completed NCT01626703 - Effect of Depressin Screening and Care Program at Community Health Center N/A
Completed NCT00582829 - Colorectal Cancer Screening Intervention for Family Members of Colorectal Cancer Patients Phase 0
Enrolling by invitation NCT04171830 - Clinical Surveillance Tool to Screen for Unmet Palliative Needs Among Patients in the Final Year of Life N/A
Completed NCT05489978 - Effectiveness of a Cervical Cancer Stigma Reduction Intervention Program on Cancer Stigma Score and Cervical Cancer Screening Uptake in Nepal N/A
Completed NCT04684316 - Economic Evaluation of Periodic Occupational Health Screening N/A
Completed NCT01427829 - Computer-assisted Psychosocial Risk Assessment (CaPRA) for Refugee Health and Settlement N/A
Recruiting NCT04221854 - Stool-based SDC2 DNA Methylation Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer N/A